Marshall Wace
AONC

Marshall Wace’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Marshall Wace’s Portfolio AONC Stock Details AONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,545,109
Closed -$15.5M – 3274
2022
Q4 		$15.5M Hold
1,545,109
– – 0.03% 576
2022
Q3 		$15.2M Buy
1,545,109
+149,300
+11% +$1.47M 0.03% 605
2022
Q2 		$13.7M Buy
1,395,809
+44,200
+3% +$432K 0.03% 667
2022
Q1 		$13.2M Buy
1,351,609
+5,200
+0.4% +$50.5K 0.03% 689
2021
Q4 		$13M Buy
1,346,409
+89,573
+7% +$872K 0.02% 685
2021
Q3 		$12.2M Buy
1,256,836
+255,948
+26% +$2.48M 0.05% 446
2021
Q2 		$9.71M Buy
+1,000,888
New +$9.8M 0.04% 499

Other funds holding AONC

CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return

Marshall Wace's AONC Position: Q1 2023 in Review

Marshall Wace sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2023, closing a stake of 1,545,109 shares — an estimated $15.5M sold.

Marshall Wace first reported a position in AONC in Q2 2021 and held it in 7 quarters. The position peaked at $15.5M in Q4 2022. 13 funds tracked by Wall St. Rank hold AONC as of Q1 2023.

  • Marshall Wace reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Marshall Wace sold 1,545,109 American Oncology Network, Inc. Class A Common Stock shares in Q1 2023, an estimated $15.5M.
  • Marshall Wace first reported a position in American Oncology Network, Inc. Class A Common Stock in Q2 2021 and held it in 7 quarters.
  • Marshall Wace's American Oncology Network, Inc. Class A Common Stock position peaked at $15.5M in Q4 2022.
  • 13 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2023.

Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.